| Patent Number |
Title Of Patent |
Date Issued |
| 7311921 |
Multi-subtype FIV vaccines |
December 25, 2007 |
| The subject invention pertains to novel methods and compositions for protecting cats from infection by a broad range of FIV strains using a multi-subtype FIV vaccine. Multi-subtype FIV vaccines comprising either cell free whole virus or cell lines infected with viruses are described. |
| 7267824 |
Multi-subtype FIV vaccines |
September 11, 2007 |
| The subject invention pertains to novel methods and compositions for protecting cats from infection by a broad range of FIV strains using a multi-subtype FIV vaccine. Multi-subtype FIV vaccines comprising either cell free whole virus or cell lines infected with viruses are described. |
| 6875773 |
Combination therapy for treatment of FIV infection |
April 5, 2005 |
| The present invention pertains to methods for therapeutic and prophylactic treatment of cats against FIV infection. Methods of the present invention utilize a combination of antiretroviral compounds to treat or prevent FIV infection in a feline animal. In one embodiment, the method compr |
| 6605282 |
Multi-subtype FIV vaccines |
August 12, 2003 |
| The subject invention pertains to novel methods and compositions for protecting cats from infection by a broad range of FIV strains using a multi-subtype FIV vaccine. Multi-subtype FIV vaccines comprising either cell free whole virus or cell lines infected with viruses are described. |
| 6544528 |
Multi-subtype FIV vaccines |
April 8, 2003 |
| The subject invention pertains to novel methods and compositions for protecting cats from infection by a broad range of FIV strains using a multi-subtype FIV vaccine. Multi-subtype FIV vaccines comprising either cell free whole virus or cell lines infected with viruses are described. |
| 6447993 |
Multi-subtype FIV vaccines |
September 10, 2002 |
| The subject invention pertains to novel methods and compositions for protecting cats from infection by a broad range of FIV strains using a multi-subtype FIV vaccine. Multi-subtype FIV vaccines comprising either cell free whole virus or cell lines infected with viruses are described. |
| 6254872 |
Multi-subtype FIV vaccines |
July 3, 2001 |
| The subject invention pertains to novel methods and compositions for protecting cats from infection by a broad range of FIV strains using a multi-subtype FIV vaccine. Multi-subtype FIV vaccines comprising either cell free whole virus or cell lines infected with viruses are described. |
| 6107077 |
Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines |
August 22, 2000 |
| Compositions derived from a novel viral isolate designated feline immunodeficiency virus (FIV) include the whole virus, proteins, polypeptides and, polynucleotide sequences derived from the virus; and antibodies to antigenic sites on the virus. These compositions are useful in a vari |
| 5968514 |
Methods for stimulating immune responses in a host through the administration of superantigen pe |
October 19, 1999 |
| The human immunodeficiency virus (HIV) contains, in addition to the canonical genes gag, pol, and env, an open reading frame in the 3' region of the genome that overlaps with the 3' long terminal repeat (LTR). Initial studies on the protein encoded by this ORF revealed a negative eff |
| 5846825 |
Feline derived T-cell lines for producing FIV |
December 8, 1998 |
| The subject invention pertains to novel methods and compositions for protecting cats from infection by a broad range of FIV strains using a multi-subtype FIV vaccine. Multi-subtype FIV vaccines comprising either cell free whole virus or cell lines infected with viruses are described. |
| 5565319 |
Assay and apparatus for detecting feline immunodeficiency virus |
October 15, 1996 |
| Compositions derived from a novel viral isolate designated feline T-lymphotropic lentivirus (FTLV) include the whole virus; proteins, polypeptides and, polynucleotide sequences derived from the virus; and antibodies to antigenic sites on the virus. These compositions are useful in a |
| 5519114 |
Retroviral superantigens, superantigen peptides, and methods of use |
May 21, 1996 |
| The subject invention concerns novel superantigen proteins and peptides and methods of use of these superantigens. Specifically exemplified are peptide agonists from mouse mammary tumor virus, feline immunodeficiency virus and human immunodeficiency virus. The peptides can also be used t |
| 5510106 |
Methods and compositions for vaccinating against feline immunodeficiency virus |
April 23, 1996 |
| Compositions derived from a novel viral isolate designated feline immunodeficiency virus (FIV) include the whole virus, proteins, polypeptides and, polynucleotide sequences derived from the virus; and antibodies to antigenic sites on the virus. These compositions are useful in a vari |
| 5275813 |
Methods and compositions for vaccinating against feline immunodeficiency virus |
January 4, 1994 |
| Compositions derived from a novel viral isolate designated feline immunodeficiency virus (FIV) include the whole virus, proteins, polypeptides and, polynucleotide sequences derived from the virus; and antibodies to antigenic sites on the virus. These compositions are useful in a vari |
| 5118602 |
Feline T-lymphotropic lentivirus assay |
June 2, 1992 |
| Compositions derived from a novel viral isolate designated feline T-lymphotropic lentivirus (FTLV) include the whole virus; proteins, polypeptides and, polynucleotide sequences derived from the virus; and antibodies to antigenic sites on the virus. These compositions are useful in a |
| 5037753 |
Feline t-lymphotropic lentivirus |
August 6, 1991 |
| Compositions derived from a novel viral isolate designated feline T-lymphototropic lentivirus (FTLV) include the whole virus; proteins, polypeptides and, polynucleotide sequences derived from the virus; and antibodies to antigenic sites on the virus. These compositions are useful in |
